RespiDART: Frontiers in Drug Development against Respiratory Viruses

Medicine & Life Sciences

1. Viruses 100%
2. Drug Development 86%
3. Antiviral Agents 45%
4. Posters 45%
5. Vaccines 39%
6. Epidemiology 27%
7. Middle East Respiratory Syndrome Coronavirus 26%
8. Viral Vaccines 25%
9. Metapneumovirus 25%
10. Occupational Groups 25%
11. Paramyxoviridae Infections 23%
12. Host Microbial Interactions 22%
13. Delivery of Health Care 21%
14. Clinical Pharmacology 21%
15. Allergy and Immunology 18%
16. Vulnerable Populations 18%
17. Hepatitis C 18%
18. Orthomyxoviridae 17%
19. Virus Replication 17%
20. Congresses 17%
21. Therapeutics 17%
22. Hepatitis B 17%
23. Geriatrics 16%
24. Drug Resistance 16%
25. Meals 15%
26. Disease Outbreaks 15%
27. Cell Culture Techniques 13%
28. Public Health 12%
29. Students 12%
30. HIV 12%
31. Elderly 11%
32. Clinical Trials 11%
33. Pediatrics 11%
34. Education 11%
35. Animals 8%
36. Health 8%
37. Population 6%